Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387308-16-000190
Filing Date
2016-04-18
Accepted
2016-04-15 21:30:52
Documents
65
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K (A/1) form10ka1.htm 10-K/A 60957
2 EX 31.1 ex31.htm EX-31.1 8931
3 EX 32.1 ex32.htm EX-32.1 4984
4 LOGO aximlogo1.jpg GRAPHIC 15392
  Complete submission text file 0001387308-16-000190.txt   1907425

Data Files

Seq Description Document Type Size
5 EX 101.INS axim-20151231.xml EX-101.INS 227029
6 EX 101.SCH axim-20151231.xsd EX-101.SCH 67357
7 EX 101.DEF axim-20151231_def.xml EX-101.DEF 28813
8 EX 101.CAL axim-20151231_cal.xml EX-101.CAL 6009
9 EX 101.LAB axim-20151231_lab.xml EX-101.LAB 269824
10 EX 101.PRE axim-20151231_pre.xml EX-101.PRE 161309
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54296 | Film No.: 161575627
SIC: 2834 Pharmaceutical Preparations